# reload+after+2024-01-21 15:47:42.353742
address1§285 East Grand Avenue
city§South San Francisco
state§CA
zip§94080
country§United States
phone§650 416 1192
website§https://unitybiotechnology.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of age-related eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.
fullTimeEmployees§22
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Anirvan  Ghosh Ph.D.', 'age': 59, 'title': 'CEO & Director', 'yearBorn': 1964, 'fiscalYear': 2022, 'totalPay': 1079300, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Nathaniel E. David A.B., Ph.D.', 'age': 55, 'title': 'Co-Founder & Executive Director', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 40000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Lynne Marie Sullivan', 'age': 56, 'title': 'CFO & Head of Corporate Development', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 730818, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Jan M. van Deursen', 'title': 'Founder', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Judith  Campisi Ph.D.', 'title': 'Founder', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Daohong  Zhou M.D.', 'title': 'Founder', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Nathan  Guz Ph.D.', 'title': 'Vice President of Operations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Alexander  Azoy', 'age': 47, 'title': 'Chief Accounting Officer & Principal Accounting Officer', 'yearBorn': 1976, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Przemyslaw  Sapieha Ph.D.', 'title': 'Chief Scientist', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Alexander Hieu Nguyen J.D.', 'age': 46, 'title': 'General Counsel & Corporate Secretary', 'yearBorn': 1977, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§4
boardRisk§9
compensationRisk§10
shareHolderRightsRisk§8
overallRisk§9
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.726
priceToSalesTrailing12Months§Infinity
currency§USD
dateShortInterest§1702598400
forwardEps§-2.71
exchange§NMS
quoteType§EQUITY
shortName§Unity Biotechnology, Inc.
longName§Unity Biotechnology, Inc.
firstTradeDateEpochUtc§1525354200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§c2edec7a-764a-3a4e-b0b1-260433147873
gmtOffSetMilliseconds§-18000000
targetHighPrice§10.0
targetLowPrice§4.0
targetMeanPrice§6.5
targetMedianPrice§6.0
recommendationMean§1.5
recommendationKey§strong_buy
numberOfAnalystOpinions§4
quickRatio§5.52
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
